• SENSEX 81,481.86
    143.91 (+0.18%)
  • BANKNIFTY 56,150.70
    -71.30 (--0.13%)
  • CG Power & Ind
    666.90 874.50(%)
  • New India Assura
    207.25 302.80(%)
  • Vimta Labs
    623.60 235.00(%)
  • Jayaswal Neco
    54.06 55.34(%)
  • GNG Electronics
    364.00 364.00(%)
  • Tata Motors
    665.45 542.55(%)
  • Varun Beverages
    534.00 680.28(%)
  • Larsen & Toubro
    3,685.00 3,963.00(%)
  • Avenue Super.
    4,324.00 5,484.00(%)
  • Waaree Energies
    3,121.30 1,808.65(%)
  • HDB FINANC SER
    797.75 891.65(%)
  • Paradeep Phosph.
    205.30 78.75(%)
  • Bharti Airtel
    1,939.00 2,045.50(%)
  • Hitachi Energy
    21,350.00 21,350.00(%)
  • Godfrey Phillips
    9,526.50 9,824.00(%)
  • Reliance Industr
    1,401.35 1,115.55(%)
  • Indian Energy Ex
    138.50 244.35(%)
  • Zuari Agro Chem.
    296.90 296.90(%)
  • Ceinsys Tech
    1,760.40 2,105.00(%)
  • Hind Rectifiers
    2,001.15 2,001.15(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Kilitch Drugs (India) Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 3630.0
  • ISIN : INE729D01010
443.90 4 (0.89%)
  • As on 30 Jul 2025 (EOD)

  • Today’s Low

    443.90

  • Today’s High

    445.00

  • Open

    445.00

  • Perv Close

    440.00

  • 52W Low

    293.53

  • 52W High

    500.00

Key Indicators

  • P/E(TTM)

    24.97

  • Mar.Cap (₹Cr.)

    775.97

  • Div & Yield %

    0.00

  • Book Value(₹)

    173.26

  • Debt-Equity Ratio

    0.89

  • AGM Date

    30-Jul-2025

  • EPS

    17.82

  • P/E Ratio

    24.97

Financials Ratios

  • Debt-Equity Ratio

    0.16

  • Mar.Cap (₹Cr.)

    775.97

  • RONW (%)

    8.28

  • ROCE (%)

    13.30

Score Board

  • Equity (₹ in Cr.)

    17.48

  • BV (₹)

    173.30

  • Sales( ₹ in Cr.)

    181.59

  • NP (in Cr.)

    31.16

  • NP Var(%)

    86.0

  • Div%

    0.0

  • CPS (₹)

    18.80

  • EPS (₹)

    17.80

  • Traded Value (₹ in Lakhs)

    777.72

  • 52 Week High

    500.00

  • 52 Week Low

    293.53

  • Price BSE

    445.0

  • Price NSE

    444.00

  • Market Capital( in Cr.)

    777.72

  • P/C Ratio

    23.60

  • P/E Ratio

    25.00

  • Price Vs.BV

    17.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 131.60 117.78 105.16 70.02 60.77 96.42
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 131.60 117.78 105.16 70.02 60.77 96.42
Other Income 6.19 4.60 4.56 4.19 5.71 4.52
Stock Adjustments 0.12 -0.23 0.05 -1.09 0.73 0.18
Total Income 137.91 122.15 109.77 73.12 67.21 101.12
EXPENDITURE :            
Raw Materials 66.33 58.27 60.29 37.97 36.49 53.16
Power and Fuel Cost 2.36 2.15 2.00 1.57 1.62 1.41
Employee Cost 7.91 7.47 6.15 5.22 5.65 5.23
Other Manufacturing Expenses 4.69 5.37 5.91 5.48 4.62 3.80
Selling and Administration Expenses 26.71 23.08 16.48 11.11 11.12 12.13
Miscellaneous Expenses 3.29 3.88 3.25 2.25 0.40 4.00
Employee Benefit Expenses 7.91 7.47 6.15 5.22 5.65 5.23
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 111.29 100.22 94.08 63.59 59.91 79.74
Operating Profit 26.62 21.94 15.69 9.53 7.31 21.38
Interest 2.02 1.15 0.80 0.88 0.93 0.65
Gross Profit 24.60 20.79 14.89 8.65 6.38 20.73
Depreciation 1.24 1.34 0.96 1.14 1.15 1.20
Profit Before Tax 23.36 19.45 13.93 7.51 5.23 19.53
Current Tax 6.37 4.20 3.63 1.67 0.70 4.24
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.59 -0.47 -0.23 -0.31 0.07 0.52
Reported Net Profit 17.57 15.72 10.53 6.16 4.46 14.77
Extraordinary Items 0.86 0.77 1.00 0.94 1.55 1.72
Adjusted Net Profit 16.71 14.95 9.53 5.22 2.91 13.05
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 113.96 98.24 87.71 81.56 78.03 64.19
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.93 0.93
P & L Balance carried down 131.53 113.96 98.24 87.71 81.56 78.03
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 5.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.50
Earnings Per Share-Unit Curr 10.93 10.09 6.76 3.97 2.89 9.62
Earnings Per Share(Adj)-Unit Curr 10.70 9.87 6.62 3.89 2.83 9.41
Book Value 138.61 122.53 112.65 105.16 98.25 98.39
Book Value(Adj)-Unit Curr 135.64 119.91 110.24 102.91 96.15 96.29

Shareholding Pattern

  • Promoter Group

    69.23%

  • Public Share Holding

    30.77%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 6,629,342 41.22 6,629,342 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 4,504,831 28.01 4,504,831 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 11,134,173 69.23 11,134,173 4
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 100 0.00 100 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 341 0.00 341 3
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 441 0.00 441 4
2] Non Institution
Bodies Corporate 285,531 1.78 284,431 48
Clearing Members 470 0.00 470 3
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 200 0.00 0 1
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 172,106 1.07 172,106 158
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 139,174 0.87 139,174 245
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,509,400 9.39 1,509,400 19
Individuals holding nominal share capital up to Rs. 1 lakh 2,597,391 16.15 2,246,119 9,891
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 232,916 1.45 232,916 1
Sub Total 4,947,705 30.76 4,595,133 10,371
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 16,082,319 100.00 15,729,747 10,379

Company Background

Kilitch Drugs (India) LtdPharmaceuticals - Indian - Formulations

  • Kilitch Drugs (India) Ltd
  • BSE Code : 3630.0
  • ISIN : INE729D01010

  • Incorporation Year

    1992

  • Registered Office

    C-301/2 MIDC TTC Indl Area
    Pawane Village, Thane,
    Maharashtra-400705

  • Telephone

    91-022-27670322/27680913/65144185

  • FAX

    91-022-27680912

  • Chairman

    Mukund P Mehta

  • Managing Director

    Mukund P Mehta

  • Company Secretary

    Pushpa Nyoupane

  • Auditor

    Suryaprakash Maurya & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Kilitch Drugs (India) Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Kilitch Drugs 444.90 137.79 131.60 24.97 10.74
Abbott India 35,188.85 6,684.73 6,409.15 52.87 44.95
Astrazeneca Phar 9,291.00 1,756.92 1,716.29 200.67 32.94
P & G Health Ltd 5,950.15 1,166.89 1,151.26 39.32 39.76
Glaxosmi. Pharma 3,194.70 3,866.05 3,723.49 58.89 58.72
Cipla 1,559.80 20,029.57 19,044.85 23.31 21.40
Amrutanjan Healt 664.40 437.58 421.23 37.79 20.84
Guj. Themis Bio. 388.35 174.19 169.82 86.69 44.82
Fermenta Biotec. 376.85 442.21 430.53 16.41 17.61
Bliss GVS Pharma 184.05 703.42 667.20 27.51 9.16
Ambalal Sarabhai 33.09 19.33 4.04 30.64 2.10